Chemoinformaics analysis of Ingenol 20-hexadecanoate
| Molecular Weight | 572.827 | nRot | 15 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 20 |
| Exact Molecular Weight | 572.408 | nRing | 4 |
| Solubility: LogS | -4.094 | nHRing | 0 |
| Solubility: LogP | 8.391 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 97 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 100.602 |
| nHD | 3 | BPOL | 59.6516 |
| QED | 0.113 |
| Synth | 6.003 |
| Natural Product Likeliness | 2.077 |
| NR-PPAR-gamma | 0.377 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.355 |
| Pgp-sub | 0.979 |
| HIA | 0.043 |
| CACO-2 | -4.993 |
| MDCK | 0.0000164 |
| BBB | 0.428 |
| PPB | 0.968292 |
| VDSS | 0.829 |
| FU | 0.0181802 |
| CYP1A2-inh | 0.05 |
| CYP1A2-sub | 0.13 |
| CYP2c19-inh | 0.588 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.45 |
| CYP2c9-sub | 0.857 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.018 |
| CYP3a4-inh | 0.76 |
| CYP3a4-sub | 0.139 |
| CL | 9.3 |
| T12 | 0.051 |
| hERG | 0.887 |
| Ames | 0.017 |
| ROA | 0.995 |
| SkinSen | 0.927 |
| Carcinogencity | 0.124 |
| EI | 0.598 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.938 |
| Antiviral | No |
| Prediction | 0.674952 |